Jun 24, 2026 – 10.55amNeurotechnology and medical device company Control Bionics has launched a $10 million capital raising to boost its balance sheet and scale the business after riding a 45 per cent share price gain over the past month.Jeremy Steele, CEO of Control Bionics. Eamon GallagherSarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones.Kanika Sood is a journalist based in Sydney who writes for the Street Talk column.Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review.Subscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber?
Control Bionics plots next phase with $10m capital raising
The $36 million market cap company is raising funds via joint lead managers Bell Potter and Unified Capital Partners.
140 words~1 min read
